Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral.
about
HPV and Cervical Cancer: Updates on an Established RelationshipHuman papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesionsHuman papillomavirus and cervical cancer: biomarkers for improved prevention effortsA genome-wide association study identifies two new cervical cancer susceptibility loci at 4q12 and 17q12Post Approval Human Papillomavirus Vaccine Uptake Is Higher in Minorities Compared to Whites in Girls Presenting for Well-Child Care.Human papillomavirus testing with Pap triage for cervical cancer prevention in Canada: a cost-effectiveness analysis.Epidemiologic natural history and clinical management of Human Papillomavirus (HPV) Disease: a critical and systematic review of the literature in the development of an HPV dynamic transmission modelOptimal threshold for a positive hybrid capture 2 test for detection of human papillomavirus: data from the ARTISTIC trial.Prevalence of HPV infection among Greek women attending a gynecological outpatient clinicPerformance of high-risk human papillomavirus DNA testing as a primary screen for cervical cancer: a pooled analysis of individual patient data from 17 population-based studies from China.Prevalence of various human papillomavirus (HPV) genotypes among women who subjected to routine Pap smear test in Bushehr city (south west of Iran) 2008-2009Prevalence and cumulative incidence of abnormal cervical cytology among HIV-infected Thai women: a 5.5-year retrospective cohort study.Persistent human papillomavirus infection and cervical neoplasia: a systematic review and meta-analysisAccuracy and cost-effectiveness of cervical cancer screening by high-risk human papillomavirus DNA testing of self-collected vaginal samples.Inverse association between methylation of human papillomavirus type 16 DNA and risk of cervical intraepithelial neoplasia grades 2 or 3Protecting the underscreened women in developed countries: the value of HPV testSignature sequence validation of human papillomavirus type 16 (HPV-16) in clinical specimens.Genome-wide screening of DNA copy number alterations in cervical carcinoma patients with CGH+SNP microarrays and HPV-FISH.A four-gene methylation marker panel as triage test in high-risk human papillomavirus positive patients.Comparison of Hybrid capture 2 testing at different thresholds with cytology as primary cervical screening test.Methylomic analysis identifies frequent DNA methylation of zinc finger protein 582 (ZNF582) in cervical neoplasmsHigh-resolution melting molecular signatures for rapid identification of human papillomavirus genotypesRandomized clinical evaluation of self-screening for anal cancer precursors in men who have sex with men.Comparison between the Hybrid Capture II Test and an SPF1/GP6+ PCR-based assay for detection of human papillomavirus DNA in cervical swab samples.Estimating the cost of cervical cancer screening in five developing countriesValidity and reliability of using a self-lavaging device for cytology and HPV testing for cervical cancer screening: findings from a pilot study.Pilot study of a commercialized human papillomavirus (HPV) genotyping assay: comparison of HPV risk group to cytology and histology.Screening tests: a review with examplesAcceptability of human papillomavirus self testing in female adolescents.Evaluation of 37,438 consecutive cervical smear results in the Turkish population.Ki-67 immunocytochemistry in liquid based cervical cytology: useful as an adjunctive tool?Facile, comprehensive, high-throughput genotyping of human genital papillomaviruses using spectrally addressable liquid bead microarraysHPV DNA testing in population-based cervical screening (VUSA-Screen study): results and implications.Detection of Human Papillomavirus Infections at the Single-Cell Level.Timeliness of cervical cancer diagnosis and initiation of treatment in the National Breast and Cervical Cancer Early Detection ProgramTriage of high-risk human papillomavirus-positive women by methylated POU4F3.Cost-Effectiveness of Different Cervical Screening Strategies in Islamic Republic of Iran: A Middle-Income Country with a Low Incidence Rate of Cervical Cancer.Human papillomavirus anogenital disease in HIV-infected individuals.The PapilloCheck Assay for Detection of High-Grade Cervical Intraepithelial Neoplasia.Modeling human papillomavirus and cervical cancer in the United States for analyses of screening and vaccination.
P2860
Q22305479-6FCA4872-3D0D-4531-BC0A-B111E13990E9Q24198236-C5195CC1-B6C1-45DB-9B2F-650E04E09644Q27023127-76202EF1-18C2-4330-992D-EA4D9F04B7C4Q28943277-374DDC9A-6516-46C2-9905-83D26F9B0DD9Q30371237-EB3CF51D-3C31-4F82-A4DE-862E291BC7EBQ30878077-8CAA8812-4C8E-45B2-BD23-000C4C75CA68Q33488325-F5F5BF66-E297-4EAD-A937-ED2490CC9E43Q33518244-8FF5C257-414E-47F5-B38D-E39A188E8DD2Q33531346-D8163060-6830-4AB0-BC76-F9A41C1261BDQ33746081-2F132F29-91B7-48F7-8CA9-BAB4B96C3BDAQ33764218-9ECBA81B-0C9F-4976-921E-2BE03F81E0D2Q33787551-36ADFED1-CA40-4F14-8A1B-82625AB0A85AQ33883532-AFA9F247-C7F2-478E-82F4-1FE68BDA4CAFQ33969401-5D5A717B-0DA6-4984-BEC9-1DCAD4601138Q34009689-18455437-A49B-4F54-AC31-1530D9895A5BQ34062696-86066F7C-E856-473C-B9A8-EDA1C0D08005Q34064401-9730EE12-1178-4EDC-B4D2-17EF853FBDE8Q34121517-F6ECFBB5-DB04-4C55-8172-B7876E59FCB3Q34204227-D7C7E0CB-4690-499C-BCDC-C082A2FD2302Q34250191-AEE485C0-B61A-45EB-9D11-978EAEE01068Q34345597-D1464A47-A5F4-426B-8250-13C462757073Q34390791-CF6FAD41-97FF-42C5-AAD7-EE3CBC58AF2DQ34537718-FE0D441D-840D-4F74-8C49-4F52A486975EQ34680765-BAF7999D-42A2-47A4-9BD7-803329DA6C34Q35039416-5F7C939E-CC96-4953-A47B-3413767DB326Q35077545-E7095C49-5B71-4A8D-BECB-2D72474108AFQ35220798-B57D4129-F4F2-4E08-8C14-21948E764275Q35317799-71D5F0C5-4915-4734-898F-29EC0CF6EA90Q35531972-E4C6D7CA-826E-4478-B712-DE345E16C9FFQ35582794-3EEA2B82-5C80-4403-94BE-A5A7AF1F7DCCQ35587035-7934BBC8-3DA1-4A7E-993E-25D56C285343Q35789859-D446FF9E-324A-45B5-A9C6-B223DB0E5242Q35835143-A729002B-50E5-4E2A-83C2-D20668EB0E2AQ35907151-4A015FA6-F348-43A9-B7D9-556738D90882Q35985039-A30FC348-E6AC-4C48-A4C4-913547BEB49EQ35986654-A946D2D9-F1B1-417C-B3F9-8EA2705E38EDQ36045104-091C6165-791C-4ED6-9F5C-0B5A7665494DQ36103164-98CF108E-05F0-49F5-AB43-20CC820B718BQ36173887-506381F5-4CD2-4073-84FD-1F11E45D0DAAQ36404994-325BFD4A-9DC4-4D4B-828C-8AC9ECDAE552
P2860
Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral.
description
2002 nî lūn-bûn
@nan
2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Evaluation of human papillomav ...... ty, and frequency of referral.
@ast
Evaluation of human papillomav ...... ty, and frequency of referral.
@en
Evaluation of human papillomav ...... ty, and frequency of referral.
@nl
type
label
Evaluation of human papillomav ...... ty, and frequency of referral.
@ast
Evaluation of human papillomav ...... ty, and frequency of referral.
@en
Evaluation of human papillomav ...... ty, and frequency of referral.
@nl
prefLabel
Evaluation of human papillomav ...... ty, and frequency of referral.
@ast
Evaluation of human papillomav ...... ty, and frequency of referral.
@en
Evaluation of human papillomav ...... ty, and frequency of referral.
@nl
P2093
P356
P1476
Evaluation of human papillomav ...... ty, and frequency of referral.
@en
P2093
Constance Mao
James P Hughes
Jane M Kuypers
Laura A Koutsky
Nancy B Kiviat
Noel S Weiss
Shalini L Kulasingam
P304
P356
10.1001/JAMA.288.14.1749
P407
P577
2002-10-01T00:00:00Z